Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  International journal of pharmaceutics

• Publication date

  2010-01-29

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ijpharm.2009.10.031PMID 19854253
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral Delivery of Peptide Drugs

  2012cited by this paper
• Improved absorption of salmon calcitonin by ultraflexible liposomes through intranasal delivery.

  2009cited by this paper
• Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules.

  2009cited by this paper
• Lipid--an emerging platform for oral delivery of drugs with poor bioavailability.

  2009cited by this paper
• Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation.

  2009cited by this paper
• Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?

  2007cited by this paper
• Carrier-mediated delivery of peptidic drugs for cancer therapy.

  2006cited by this paper
• Efficacy and Mechanism of Action of Chitosan Nanocapsules for Oral Peptide Delivery

  2006cited by this paper
• Is the oral route possible for peptide and protein drug delivery?

  2006cited by this paper
• Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats.

  2006cited by this paper
• Effect of chitosan on the intranasal absorption of salmon calcitonin in sheep

  2005cited by this paper
• Oral delivery of peptide drugs: barriers and developments.

  2005cited by this paper
• Protein drug stability: a formulation challenge

  2005cited by this paper
• Safety and Efficacy of a Novel Salmon Calcitonin (sCT) Technology‐Based Oral Formulation in Healthy Postmenopausal Women: Acute and 3‐Month Effects on Biomarkers of Bone Turnover

  2004cited by this paper
• Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.

  2004cited by this paper
• Regional permeability of salmon calcitonin in isolated rat gastrointestinal tracts: Transport mechanism using Caco-2 cell monolayer

  2004cited by this paper
• Formulation design of double-layer in the outer shell of dry-coated tablet to modulate lag time and time-controlled dissolution function: Studies on micronized ethylcellulose for dosage form design (VII)

  2004cited by this paper
• Intestinal paracellular permeation enhancement with quaternised chitosan: in situ and in vitro evaluation.

  2002cited by this paper
• Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia.

  2002cited by this paper
• Oral drug absorption enhancement by chitosan and its derivatives.

  2001cited by this paper
• ENHANCEMENT OF NASAL ABSORPTION OF CALCITONIN LOADED IN LIPOSOMES

  2001cited by this paper
• Chitosan and its derivatives in mucosal drug and vaccine delivery.

  2001cited by this paper
• Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems.

  2000cited by this paper
• Oral delivery of salmon calcitonin.

  2000cited by this paper
• Transmucosal delivery systems for calcitonin: a review.

  2000cited by this paper
• Calcitonin.

  1999cited by this paper
• A novel skin penetration enhancer: evaluation by membrane diffusion and confocal microscopy.

  1999cited by this paper
• Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).

  1999cited by this paper
• Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments.

  1999cited by this paper
• Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).

  1998cited by this paper
• Chitosans for enhanced delivery of therapeutic peptides across intestinal epithelia: in vitro evaluation in Caco-2 cell monolayers

  1997cited by this paper
• Using microemulsion formulations for oral drug delivery of therapeutic peptides

  1995cited by this paper
• Bioadhesive analysis of controlled-release systems. IV. An experimental method for testing the adhesion of microparticles with mucus

  1990cited by this paper

• A Comprehensive Review of Advanced Nasal Delivery: Specially Insulin and Calcitonin.

  2023cites this paper
• Nose-to-Brain (N2B) Delivery: An Alternative Route for the Delivery of Biologics in the Management and Treatment of Central Nervous System Disorders

  2023cites this paper
• Advanced Drug Delivery Systems for Biologics

  2021cites this paper
• A toxicity profile of the Pheroid® technology in rodents

  2019cites this paper
• Development and validation of an LC-MS/MS method for the quantification of goserelin in a Pheroid® formulation, in simulated intestinal fluid.

  2019cites this paper
• In Vitro-In Vivo Evaluation of an Oral Ghost Drug Delivery Device for the Delivery of Salmon Calcitonin.

  2018cites this paper
• Nano- and Pheroid technologies for development of foliar iron fertilizers and iron biofortification of soybean grown in South Africa

  2018cites this paper
• Advanced formulations for intranasal delivery of biologics

  2018cites this paper
• Development and Evaluation of Lamotrigine loaded N-Trimethyl Chitosan Microspheres for Intranasal Administration

  2017cites this paper
• Transcutaneous permeation of antiviral agents

  2017cites this paper
• Development of risperidone liposomes for brain targeting through intranasal route.

  2016cites this paper
• Exploratory data analysis of the dependencies between skin permeability, molecular weight and log P.

  2016cites this paper
• Recent Advances in Non-Invasive Delivery of Macromolecules using Nanoparticulate Carriers System.

  2016cites this paper
• Nasal Absorption of Macromolecules from Powder Formulations and Effects of Sodium Carboxymethyl Cellulose on Their Absorption

  2016cites this paper
• Essential Fatty Acids as Transdermal Penetration Enhancers.

  2016cites this paper
• Topical delivery of acyclovir and ketoconazole

  2016cites this paper
• Delivery of Therapeutic Proteins: Challenges and Strategies.

  2016cites this paper
• Preparation and cytotoxicity of N-modified chitosan nanoparticles applied in curcumin delivery.

  2016cites this paper
• In vivo efficacy and bioavailability of lumefantrine: Evaluating the application of Pheroid technology.

  2015cites this paper
• N-trimethyl chitosan (TMC)-modified microemulsions for improved oral bioavailability of puerarin: preparation and evaluation

  2015cites this paper
• Vesicular carriers for skin drug delivery: the Pheroid™ technology.

  2015cites this paper
• Comparing Antibody Responses in Chickens Against Plasmodium falciparum Lactate Dehydrogenase and Glyceraldehyde-3-phosphate Dehydrogenase with Freund#’s and Pheroid#® Adjuvants

  2015influential citation
• Preparation and characterization of bioadhesive microparticles comprised of low degree of quaternization trimethylated chitosan for nasal administration: effect of concentration and molecular weight.

  2014cites this paper
• Oral peptide and protein delivery: intestinal obstacles and commercial prospects

  2014cites this paper
• Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.

  2014cites this paper
• Formulation and evaluation of Pheroid vesicles containing mefloquine for the treatment of malaria

  2014cites this paper
• Biologics: the role of delivery systems in improved therapy

  2014cites this paper
• Pheroid™ Vesicles and Microsponges for Nasal Delivery of Biopharmaceuticals

  2014cites this paper
• Applications of lipid based formulation technologies in the delivery of biotechnology-based therapeutics.

  2014cites this paper
• Radio-labelling as a tool to investigate the absorption and bio-distribution of selected antimalarial drugs

  2014cites this paper
• Drug carriers for the delivery of therapeutic peptides.

  2014cites this paper
• Nose as a Route for Drug Delivery

  2013cites this paper
• Optimization of in vitro assays to study biocompatibility of lipid drug delivery systems

  2013cites this paper
• Size characterization of Pheroid TM formulations and liposomes

  2013cites this paper
• Quantitative and qualitative determination of the entrapment ability of two lipid drug delivery systems to entrap hydrophilic and lipophilic compounds

  2013cites this paper
• Developing oral formulations for protein and peptide drugs

  2013cites this paper
• Oral delivery of peptides and proteins using lipid-based drug delivery systems

  2012cites this paper
• Strategies for non-invasive delivery of biologics

  2012cites this paper
• Orally Administered Therapeutic Peptide Delivery: Enhanced Absorption Through the Small Intestine Using Permeation Enhancers

  2012influential citation
• Formulation and evaluation of different transdermal delivery systems with flurbiprofen as marker

  2012cites this paper
• In vitro activity of Pheroid vesicles containing antibiotics against Plasmodium falciparum

  2012cites this paper
• Nanomedicine in Malaria

  2012cites this paper
• Liposomal delivery of proteins and peptides

  2012cites this paper
• Drug development of intranasally delivered peptides.

  2012cites this paper
• Evaluation of the physical properties and stability of two lipid drug delivery systems containing mefloquine.

  2011cites this paper
• Topical and Transdermal Delivery of L-Carnitine

  2011cites this paper
• In vitro antimalarial efficacy enhancement of selected antibiotics with PheroidTM technology

  2010cites this paper
• Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride

  2010cites this paper
• Nasal delivery of recombinant human growth hormone: in vivo evaluation with Pheroid technology and N-trimethyl chitosan chloride.

  2010cites this paper
• Efficacy enhancement of the antimalarial drugs, mefloquine and artesunate, with PheroidTM technology

  2010cites this paper